Ferozsons Laboratories Ltd announced financial results for the half year ending December 31st, 2017. The company reported net revenue earned worth Rs. 2.223 billion during the half year against Rs. 2.308 billion same period last year; down 3.70% from last year.
Ferozsons Laboratories Ltd reported bottom-line profits worth Rs. 73.238 million with an EPS of 2.62/share.
Comparison of Key Financials
Unconsolidated Profit and Loss Account – For the Year Ended, December 31st 2017
Key Financials
2017
2016
% Change
Amounts in PKR
Revenue – net
2,223,383,744
2,308,846,396
-3.70%
Cost of Sales
1,443,479,655
1,237,847,803
16.61%
Gross Profit
779,904,089
1,070,998,593
-27.18%
Administrative Expenses
151,868,393
136,393,046
11.35%
Selling and Administrative Expenses
473,587,770
431,114,833
9.85%
Other Expenses
28,194,640
41,612,113
-32.24%
Other Income
41,535,521
22,132,816
87.66%
Profit from Operations
167,788,807
484,011,417
-65.33%
Finance Costs
6,402,928
10,345,386
-38.11%
Profit before Taxation
161,385,879
473,666,031
-65.93%
Taxation
82,146,927
114,578,321
-28.31%
Profit after Taxation
79,238,952
359,087,710
-77.93%
EPS – Basic and diluted
2.62
11.90
-77.98%
Company release on Earnings Report can be accessed here.
